KLK7 and Netherton syndrome: Targeted protease inhibition (KLK5/KLK7 blockade): If someone has Netherton syndrome, it means they lack the LEKTI protein, which leads to KLK5 and KLK7 acting uncontrollably and causing the skin barrier to break and become inflamed.